癌症特异性基因电路通过固有核糖体移码生成
A death sentence for ‘sloppy’ cancers
Wang 等人在 Nature 上报道,某些癌症细胞在蛋白质合成过程中出现固有核糖体移码现象,导致异常蛋白质生成。这一机制可能被用于开发新的基因治疗工具,靶向肿瘤。doi: References
- NEWS AND VIEWS
- 04 November 2026
The process of making protein from RNA can go awry in cancer cells. This malfunction might be harnessed to create an effective gene-therapy tool that targets tumours.
By
-
Lorenzo Valcanover
-
Lorenzo Valcanover is in the Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.
-
-
Reuven Agami
-
Reuven Agami is in the Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands, and the Department of Genetics, Erasmus University Rotterdam, the Netherlands.
-
Identifying cellular properties that distinguish a cancer from healthy tissue is a crucial step for developing efficient treatments. One such characteristic is the ‘sloppy’ way in which some cancer cells implement translation — the process by which proteins are made from messenger RNA by protein complexes called ribosomes. This process can go awry. Writing in Nature, Wang et al.1 reveal a cancer-specific mechanism by which translation loses its normal ‘track’ of how it reads an mRNA sequence to encode the expected amino acids, resulting in a phenomenon called frameshifting. This generates proteins that have a distinct sequence of amino acids that are not usually made, and the authors show that this abnormality might be exploited for therapeutic purposes.
doi: https://doi.org/10.1038/d41586-026-03269-8
References
Wang, Q. et al. Nature https://doi.org/10.1038/s41586-026-11200-4 (2026).
Champagne, J. et al. Mol. Cell 81, 4709–4721 (2021).
Bartok, O. et al. Nature 590, 332–337 (2021).
Weller, C. et al. Cancer Cell 43, 823–840 (2025).
Kochavi, A. et al. Nucleic Acids Res. 52, 13964–13979 (2024).
Atkins, J. F., Loughran, G., Bhatt, P. R., Firth, A. E. & Baranov, P. V. Nucleic Acids Res. 44, 7007–7078 (2016).
Xavier, A. et al. Cell https://doi.org/10.1016/j.cell.2026.08.031 (2026).
Wang, X. et al. Cell 176, 625–635 (2019).
Rodnina, M. V. Annu. Rev. Biophys. 52, 161–182 (2023).
Dever, T. E., Dinman, J. D. & Green, R. Cold Spring Harb. Perspect. Biol. 10, a032649 (2018).
Coffino, P. Nature Rev. Mol. Cell Biol. 2, 188–194 (2001).
Inada, T. Nature Struct. Mol. Biol. 33, 394–407 (2026).
Wang, H. et al. Mol. Cancer 23, 268 (2024).
Byrne, B. J. et al. Mol. Ther. 33, 2479–2516 (2025).
Competing Interests
The authors declare no competing interests.
Related Articles
-
Read the paper: Cancer-selective gene circuits via intrinsic ribosomal frameshifting
-
Two-layer design protects genes from mutations in their enhancers
Subjects
Latest on:
来源:Nature 综合主刊 · nature.com
Modified messenger-RNA components alter the encoded protein